Hot Jobs

Looking for Career in Pharmacovigilance/ Clinical Research. Enter details here.

Monday, 10 February 2014

Opening for Medical Writing - Candidates who can join in 2 Weeks can a (1-3 yrs.) jobs in Mysore..m

Experience:
1 - 3 Years
Compensation:
Not Mentioned
Industry Type:
pharm/ Biotech/Clinical Research
Role:
 
Openings:
Not Mentioned



Location:
Mysore
Education:
(UG - Any Graduate - Any Specialization, B.Pharma - Pharmacy, BDS - Dentistry, MBBS - Medicine, B.Sc - Bio-Chemistry, Microbiology, Nursing)AND (PG - Any Postgraduate - Any Specialization, M.Sc - Bio-Chemistry, Nursing, Microbiology, M.S/M.D - Any Special
Functional Area:
Pharma / Biotech / Healthcare / Medical / R&D
Posted On:
07th Feb 2014
 
 

Job Description

Experience: 1 3 Years experience Literature search, Preparation of Study Documents IB & Protocol, Compilation of CSR as per ICH Writing articles for internal communicationE3 guidelines, Manuscript Writing for peer reviewed Journals Medical graduates (MBBS / BAMS / BHMS ), course in Clinical Research Medical Writing (Not Mandatory), 12 yrs experience in Clinical Research Industry with 12 yrs in Medical Writing, Proficiency in written & spoken English, MS office.
 

Company Profile

 
Synowledge PV Services India Pvt Ltd 
Synowledge is a Global Management Consulting, Technology Services and Outsourcing Company focused in the Life Sciences Healthcare Industry. With an annual growth rate of 300% and serving clients across 6 global offices (US, EU and Asia Pacific), Synowledge has gained market share to become the leading service provider in its space. Combining unparalleled experience and specialized capabilities within the Life Sciences industry, Synowledge has become a strategic partner with many Top 20 Pharma and Fortune 500 companies. Synowledge's technology solutions and innovative consulting services help life sciences companies reduce cost, accelerate growth and minimize time to market during the drug development lifecycle.






























































































 

No comments:

Post a Comment

Subscribe to us